logo de ProBioQual
Association for the Promotion of Quality Control in Medical Biology
Logo Certification ISO 9001
Haemostasis
2026 EQA SCHEMES
EQA 2026 - Fibrin and fibronogen degradation products (PDF)
Expert Biologists - Scheme Coordinators:
Chantal BON and Béatrice GUILLEMIN
EQA performed since 2023
Number of analytical sites registered in 2025: 26

1 – Scheme overview

This External Quality Assessment scheme allows an evaluation of accuracy of the screening and assay methods for Fibrin and Fibrinogen Degradation Products (FDPs) in plasma.

The main marketed reagents are represented: quantitative automated methods and manual methods (screening and semi-quantitative testing of FDPs).

3 levels of concentration are tested.

Statistical reports are sent with supporting comments from the expert clinical biologists who coordinate the scheme.

2 – Assessment frequency

Number of investigations per year: 4
Number of control samples per investigation: 1 or 2
Number of samples per year : 6

3 – List of analytes assessed 

  • FDPs (quantitative and semi-qualitative)

4 – Description of the control samples

Lyophilized human control plasma (citrate) (samples to be resuspended in 1 mL of distilled water).

Contact Us
ProBioQual
7, Rue Antoine Lumière - 69008 LYON - FRANCE
Tel : +33 (0)4 72 65 34 90
Fax : +33 (0)4 78 85 97 77
E-mail : secretariat@probioqual.com
| Legal notices and privacy policy | General Terms of Sale | Last updated : 08/09/2025 Copyright © 2011-2025 ProBioQual All rights reserved.